CatalystGeopolitics
AP report: FDA scientists opposed the Trump administration's move to ease peptides access
FDA scientists opposed easing peptide access, signaling regulatory conflict.
Context
What happened: FDA scientific staff members opposed a plan to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., according to six people familiar with its development.
Why it matters: The staff had limited input in drafting the policy, per those sources, and most of them opposed it.
Coverage: 4 outlets in 24h
What changed
FDA scientific staff members opposed a plan to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., according to six people familiar with its development.
Why it matters
The staff had limited input in drafting the policy, per those sources, and most of them opposed it.
← Dashboard
Oct 28, 2026 10:52 PM ET